Clearbridge Health's Philippine unit reports 8 cases of Covid-19
PRECISION medicine firm Clearbridge Health on Wednesday said eight people comprising patients and staff had tested positive for the novel coronavirus at its medical centre in Manila.
As a precautionary measure, Clearbridge Medical Philippines Inc (CMPI) has voluntarily ceased the affected operations and segregated non-affected operations at the medical centre for 14 days, with effect from July 8.
According to Clearbridge Health, revenue from its medical centre in the Philippines accounted for less than 5 per cent of the group's revenue in FY2019. Therefore, the temporary cessation and segregation is not expected to have any material impact on the group's financial performance for the year ending Dec 31, 2020.
The group's other operations in the Philippines are not affected, Clearbridge Health said.
Separately, Biolidics, which was spun out of Clearbridge Health, on Wednesday said it has entered into a collaboration agreement with Hangzhou-based LC-Bio to develop cancer-diagnostic solutions.
Clearbridge shares closed at 17.2 Singapore cents on Wednesday, up 0.1 cent or 0.6 per cent, while Biolidics shares finished at 31 Singapore cents, down 0.5 cent or 1.6 per cent before these announcements.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
National Day Rally: 8 things to know, from more childcare leave to higher BTO income ceiling
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
NDR 2026: Every Singaporean child to get direct financial support from birth to age 17
When every phone becomes a satellite phone, what happens to Asia’s telcos?